文献速递创伤骨科骨质疏松与代谢性骨病

预防性固定可经济有效地预防对侧双膦酸盐相关股骨骨折

Prophylactic Fixation Can Be Cost-effective in Preventing a Contralateral Bisphosphonate-associated Femur Fracture.
PubMed 文献 · Clin Orthop Relat Res · 2019-01-01

本研究采用马尔可夫模型评估双膦酸盐相关非典型股骨骨折后对侧预防性固定的成本效益。模拟60至90岁患者分为标准骨折风险组和高骨折风险组。结果显示标准风险组每质量调整生命年花费131300美元,高风险组为22400美元。结论认为对标准风险患者不具成本效益,而对高风险患者(60至89岁,具有一个以上危险因素)具有成本效益。

要点

  • 对标准骨折风险患者,预防性固定每质量调整生命年花费131300美元,不具成本效益。
  • 对高骨折风险患者,预防性固定每质量调整生命年花费22400美元,具有成本效益。
  • 模型最敏感的参数为预防性固定成本、患者年龄和预防性固定相关并发症概率。

核心结论

  • 单侧非典型股骨骨折后对侧预防性固定对标准风险患者不具成本效益,但对60至89岁、具有一个以上危险因素(如亚洲种族、前驱疼痛、股骨近端内翻几何形态、股骨弯曲或影像学改变如骨膜起翘和横向透亮线)的高风险患者具有成本效益。
  • 作者指出其发现基于建模的几个关键假设,如骨折和并发症的概率、每个健康状态的相关成本以及手术治疗的风险。
  • 作者认为未来研究应前瞻性评估已知影像学和解剖学参数所贡献的风险程度,以指导非典型股骨骨折后对侧股骨的管理。

研究设计与样本

  • 研究使用马尔可夫模型确定初始非典型股骨骨折后对侧预防性固定的成本效益。
  • 模拟患者年龄60至90岁,分为标准骨折风险组和高骨折风险组;标准风险定义为出现一处非典型股骨骨折但对侧股骨无症状或发现,高风险定义为具有一个以上危险因素,包括亚洲种族、前驱疼痛、股骨几何形态改变或对侧股骨影像学发现。
  • 结局概率和效用值来自与患者特征匹配的研究,当非典型股骨骨折数据不可用时使用脆性骨折文献;相关成本主要来自2015年Medicare报销费率。
  • 对所有模型参数在定义范围内进行敏感性分析。
  • 证据等级为III级,经济与决策分析。

主要发现

  • 对于70岁标准骨折风险患者,预防性固定每质量调整生命年花费131300美元;对于高风险患者,每质量调整生命年花费22400美元。
  • 敏感性分析显示,对于高风险患者,当预防性固定成本低于29400美元、预防性固定并发症概率低于21%或患者年龄小于89岁时,预防性固定以每质量调整生命年100000美元具有成本效益。
  • 模型最敏感的参数是预防性固定成本、患者年龄和预防性固定相关并发症的概率。

临床怎么用

  • 作者结论认为,单侧非典型股骨骨折后对侧预防性固定对标准风险患者不具成本效益,而对具有一个以上危险因素的高风险患者(60至89岁)具有成本效益。
  • 作者指出其发现基于建模的关键假设,并认为未来研究应前瞻性评估已知影像学和解剖学参数所贡献的风险程度,以指导对侧股骨的管理。

局限性

  • 作者指出其发现基于建模的几个关键假设,如骨折和并发症的概率、每个健康状态的相关成本以及手术治疗的风险。
  • 作者认为未来研究应前瞻性评估已知影像学和解剖学参数所贡献的风险程度,以指导非典型股骨骨折后对侧股骨的管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Bisphosphonates reduce the risk of fractures associated with osteoporosis but increase the risk of atypical subtrochanteric femur fractures. After unilateral atypical femur fracture, there is risk of contralateral fracture, but the indications for prophylactic fixation are controversial. QUESTIONS/PURPOSES: The purpose of this study is to use Markov modeling to determine whether contralateral prophylactic femur fracture fixation is cost-effective after a bisphosphonate-associated atypical femur fracture and, if so, what patient-related factors may influence that determination. METHODS: Markov modeling was used to determine the cost-effectiveness of contralateral prophylactic fixation after an initial atypical femur fracture. Simulated patients aged 60 to 90 years were included and separated into standard and high fracture risk cohorts. Patients with standard fracture risk were defined as those presenting with one atypical femur fracture but without symptoms or findings in the contralateral femur, whereas patients with high fracture risk were typified as those with more than one risk factor, including Asian ethnicity, prodromal pain, femoral geometry changes, or radiographic findings in the contralateral femur. Outcome probabilities and utilities were derived from studies matching to patient characteristics, and fragility fracture literature was used when atypical femur fracture data were not available. Associated costs were largely derived from Medicare 2015 reimbursement rates. Sensitivity analysis was performed on all model parameters within defined ranges. RESULTS: Prophylactic fixation for a 70-year-old patient with standard risk for fracture costs USD 131,300/quality-adjusted life-year (QALY) and for high-risk patients costs USD 22,400/QALY. Sensitivity analysis revealed that prophylaxis for high-risk patients is cost-effective at USD 100,000/QALY when the cost of prophylaxis was less than USD 29,400, the probability of prophylaxis complications was less than 21%, or if the patient was younger than 89 years old. The parameters to which the model was most sensitive were the cost of prophylaxis, patient age, and probability of prophylaxis-related complications. CONCLUSIONS: Prophylactic fixation of the contralateral side after unilateral atypical femur fracture is not cost-effective for standard-risk patients but is cost-effective among high-risk patients between 60 and 89 years of age with a high risk for an atypical femur fracture defined by patients with more than one risk factor such as Asian ethnicity, prodromal pain, varus proximal femur geometry, femoral bowing, or radiographic changes such as periosteal beaking and a transverse radiolucent line. However, our findings are based on several key assumptions for modeling such as the probability of fractures and complications, the costs associated for each health state, and the risks of surgical treatment. Future research should prospectively evaluate the degree of risk contributed by known radiographic and demographic parameters to guide management of the contralateral femur after a patient presents with an atypical femur fracture. LEVEL OF EVIDENCE: Level III, economic and decision analyses.

来源:Clin Orthop Relat Res,查看原文。版权归原作者所有。

引用

  1. Jiang SY, Kaufman DJ, Chien BY, et al. Prophylactic Fixation Can Be Cost-effective in Preventing a Contralateral Bisphosphonate-associated Femur Fracture. Clin Orthop Relat Res. 2019. PMID: 30394950. doi:10.1097/CORR.0000000000000545

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。